Precipio, Inc. — Director's Dealing 2013

Oct 8, 2013

SEC Form 4/A — Form 4/A

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2013-09-30

Reporting Person: COLONNESE MARK P (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-30	Stock Appreciation Rights	$0.36	A	660000	Acquired	2023-09-30	Common Stock (660000)	Direct

Footnotes

F1: Due to a transcription error, the original Form 4 filed on 10/3/13 incorrectly stated that 690,000 stock appreciation rights were granted instead of 660,000.

F2: The stock appreciation rights were granted on 9/30/2013 and are exercisable as they vest. The stock appreciation rights vest over a three year period, with 34% of the shares subject to the stock appreciation rights vesting on the first anniversary of the grant date and the balance vesting in 24 equal consecutive monthly installments thereafter, subject to the reporting person's continued employment with the issuer on each such date.